Stocks traded lower Wednesday morning after two very strong days in the market. China has cut bank reserve requirements, but some fears are creeping back up in Europe. Investors have bought pullbacks and sought value and overlooked stocks at each and every opportunity in the past two years. 24/7 Wall St. reviews dozens of analyst research reports each day to find new investment and trading ideas for our readers. Some of these analyst research reports cover stocks to buy, while others cover stocks to sell or avoid.

These are this Wednesday’s top analyst upgrades, downgrades and initiations.

Athenahealth Inc. (NASDAQ: ATHN) was raised to Outperform from Market Perform and the price target was raised to $172 from $134 (versus a $139.86 close) at Cowen.

BreitBurn Energy Partners L.P. (NASDAQ: BBEP) was downgraded to Underperform from Neutral at Credit Suisse.

Calix Inc. (NYSE: CALX) was downgraded to Neutral from Buy at Goldman Sachs. UBS also downgraded it to Neutral from Buy. The report is after earnings were in line with expectations.

Church & Dwight Co. (NYSE: CHD) was raised to Neutral from Underperform and the price objective was raised to $85 from $75 (versus a $82.69 close) at Bank of America Merrill Lynch.

ALSO READ: 8 Analyst Stocks Under $10 With Massive Upside

Coupons.com Inc. (NYSE: COUP) was raised to Neutral from Sell and the price target was raised to $15 from $12 (versus a $14.80 close) at Goldman Sachs.

Dean Foods Co. (NYSE: DF) was downgraded to Market Perform from Outperform at BMO Capital Markets.

Entropic Communications Inc. (NASDAQ: ENTR) has two opposite calls. It was raised to Neutral from Underperform at Credit Suisse, but it was downgraded to Hold from Buy at Needham.

Ericsson (NASDAQ: ERIC) was downgraded to Neutral from Overweight at J.P. Morgan.

Goodrich Petroleum Corp. (NYSE: GDP) was downgraded to Hold from Buy at Canaccord Genuity.

Hilton Worldwide Holdings Inc. (NYSE: HLT) was raised to Outperform from Neutral at Baird.

Iconix Brand Group Inc. (NASDAQ: ICON) was raised to Buy from Hold at Brean Capital.

Isis Pharmaceuticals Inc. (NASDAQ: ISIS) was downgraded to Neutral from Overweight at Piper Jaffray.

Myriad Genetics Inc. (NASDAQ: MYGN) has multiple calls after beating earnings but tempering guidance, and after the CEO is retiring. Myriad was raised to Outperform from Market Perform at JMP Securities. It was also downgraded to Underperform from Neutral at Credit Suisse and to Neutral from Buy at Mizuho.

ALSO READ: 5 Biotech Stocks Loved by Portfolio Managers

National Oilwell Varco Inc. (NYSE: NOV) was downgraded to Neutral from Buy at Sterne Agee.

Pacific Coast Oil Trust (NYSE: ROYT) was downgraded to Equal Weight from Overweight and the price target was slashed to $6 from $11 (versus a $5.43 close) at Barclays.

Pentair PLC (NYSE: PNR) posted earnings above estimates, but revenues were soft. The manufacturer was downgraded to Hold from Buy at KeyBanc Capital Markets and to Market Perform from Outperform at Bernstein.

Stratasys Ltd. (NASDAQ: SSYS) already saw negative analyst calls on Tuesday after its dire warning, but the 3D printing player was downgraded to Hold from Buy at Stifel and to Equal Weight from Overweight at Morgan Stanley.

ALSO READ: Are Greek Banks Finally Safe?

Waddell & Reed Financial Inc. (NYSE: WDR) traded lower despite headlines saying it beat earnings expectations. The investment firm was downgraded to Sell from Neutral at Citigroup and to Neutral from Buy at Sterne Agee.

In case you missed Tuesday’s top analyst upgrades and downgrades, they included Barclays, Caterpillar, EMC, JD.com, LinkedIn, Stratasys and over a dozen more companies.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.